Renalytix appoints Howard Doran as Chief Business Officer

Renalytix appointed Howard Doran as Chief Business Officer, effective September 1. Doran’s primary responsibility will be leading the KidneyIntelX global sales effort. Doran served as LipoScience’s President and CEO until successful completion of LabCorp’s acquisition of the company in November 2014. Preceding LipoScience, Doran was President and COO of Constitution Medical, an early-stage in vitro diagnostics company and developer of the Bloodhound Fully Integrated Hematology System, acquired by Roche Diagnostics in July 2013. Prior to Constitution Medical, Doran was a member of the senior executive team of Hologic and served as President of Hologic’s Global Diagnostics business. Doran had been serving as Senior VP and Business Unit Director of Cytyc’s in vitro diagnostics business. From 1997 through 2007, he was a member of the management team of Cytyc Corporation.